Pune (Voice news service):-A team of doctors at Noble Hospitals and Research Center successfully conducted Robotic radical distal pancreatico splenectomy procedure on a 72-year-old woman from Yemen with pancreatic tumour. The marked a milestone achievement as the 1st case in Maharashtra and the 2nd in India to be executed using the cutting-edge First Made in India Surgical Robot.
Explaining the case Dr. Lalit Banswal, senior cancer surgeon and expert in minimally invasive and robotic surgeries said that the 72 year old female patient from Yemen came to us excruciating pain in the stomach. She had undergone sonography in Yemen and was diagnosed with tumour in pancreas. By the time she decided to come to India and approach us, the tumour size had increased to 12×8 CM .
He added a pet scan pointed out to a localised tumour which was operable. Apart from the age factor, she weighed 140 kgs with a BMI of 38. She had multiple comorbidities including uncontrolled hypertension and diabetes. While open surgery is an option in some cases, here considering the complications we suggested her minimally invasive (laparoscopy) or robotic surgery.
The three-hour surgery was complex due to the comorbidities, the weight and the location of the tumour. The pancreas are surrounded by major vessels and has to be separated during the surgery. A pancreatico splenectomy, also known as a distal pancreatectomy with splenectomy, is a surgical procedure that removes the tail and body of the pancreas, and sometimes the spleen. It’s used to treat pancreatic cancer, chronic pancreatitis, and other conditions. In this case the vessel going to the spleen had to be sacrificed as it was damaged by the tumour. The procedure has to be performed with utmost precision and is critical. There are very few experts who conduct such procedures.
Dr Banswal added that robots helped carry the procedure with precision, offers easy control to the surgeon and increases the accuracy. Lesser blood loss and minimal loss to surrounding tissues means faster recovery. The patient was shifted from ICU to general room in a couple of days and made to walk (ambulate).
The histopathology report suggested serous cystadenoma (benign tumour) and so no adjuvant treatment is required, said Dr. Banswal.
Dr. Divij Mane, Director Noble Hospitals and Research Centre said that barely within a few weeks to installing the Made in India robot, the fact that our team has successfully conducted this ground-breaking surgery demonstrates the expertise of our doctors and the team to handle complex situations day in and day out. This furthers our mission to offer world class services to our patients.
Dr. Dilip Mane, Chairman and Managing Director, Noble Hospitals and Research Centre said that this landmark case exemplifies the integration of advanced technology and surgical expertise at Noble Hospital Pune.
